Please ensure Javascript is enabled for purposes of website accessibility Global Life Sciences Fund - Janus Henderson Investors

Global Life Sciences Fund

By understanding the science and business of health care, the strategy invests in companies addressing unmet medical needs or improving health care efficiencies

Overview

Quarterly update

Watch the investment team recap this quarter.

(Note: Filmed in July 2024).

OBJECTIVE AND INVESTMENT POLICY

This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.

ABOUT THIS FUND

  • Looks to invest in companies addressing unmet medical needs or making the health care system more efficient
  • Aims to maintain a balanced portfolio across subsectors (pharmaceuticals, biotechnology, health care services, and medical devices)
  • An experienced team of specialists that seeks to understand the science and the business of health care

PORTFOLIO MANAGEMENT

Andy Acker, CFA

Andy Acker, CFA

Portfolio Manager

Industry since 1996. Joined Firm in 1999.

Daniel Lyons, Ph.D., CFA

Daniel Lyons, Ph.D., CFA

Portfolio Manager | Research Analyst

Industry since 2000. Joined Firm in 2000.

Performance

Calendar Year Returns (%)
E2 USD (Net) I2 USD (Net) H2 USD (Net) A2 USD (Net) E2 USD (Net) H2 USD (Net) A2 USD (Net) I2 USD (Net) MSCI World Health Care NR MSCI World Health Care NR MSCI World Health Care NR MSCI World Health Care NR MSCI World Health Care NR MSCI World Health Care NR MSCI World Health Care NR MSCI World Health Care NR Sector Equity Healthcare - OE Sector Equity Healthcare - OE Sector Equity Healthcare - OE Sector Equity Healthcare - OE Sector Equity Healthcare - OE Sector Equity Healthcare - OE Sector Equity Healthcare - OE Sector Equity Healthcare - OE
1703980800000 1672444800000 1640908800000 1609372800000 1577750400000 1546214400000 1514678400000 1483142400000 1451520000000 1419984000000
E2 USD (Net) 4.93 -4.85 4.23 22.75 26.48 1.49 19.88 -14.19 5.19 32.01
I2 USD (Net) 6.32 -3.59 5.60 24.37 28.04 2.76 21.48 -13.17 6.55 33.68
H2 USD (Net) 7.04 -2.89 6.35 25.23 28.95 3.48 22.28 -12.49 7.24 34.73
A2 USD (Net) 5.44 -4.35 4.72 23.41 27.06 2.01 20.55 -13.79 5.69 32.75
E2 USD (Net) 4.93 -4.85 4.23 22.75 26.48 1.49 19.88 -14.19 5.19 32.01
H2 USD (Net) 7.04 -2.89 6.35 25.23 28.95 3.48 22.28 -12.49 7.24 34.73
A2 USD (Net) 5.44 -4.35 4.72 23.41 27.06 2.01 20.55 -13.79 5.69 32.75
I2 USD (Net) 6.32 -3.59 5.60 24.37 28.04 2.76 21.48 -13.17 6.55 33.68
MSCI World Health Care NR 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
MSCI World Health Care NR 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
MSCI World Health Care NR 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
MSCI World Health Care NR 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
MSCI World Health Care NR 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
MSCI World Health Care NR 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
MSCI World Health Care NR 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
MSCI World Health Care NR 3.76 -5.41 19.80 13.52 23.24 2.51 19.80 -6.81 6.60 18.10
Sector Equity Healthcare - OE 2.67 -13.91 7.12 20.53 21.80 -3.40 21.68 -9.37 5.90 18.33
Sector Equity Healthcare - OE 2.67 -13.91 7.12 20.53 21.80 -3.40 21.68 -9.37 5.90 18.33
Sector Equity Healthcare - OE 2.67 -13.91 7.12 20.53 21.80 -3.40 21.68 -9.37 5.90 18.33
Sector Equity Healthcare - OE 2.67 -13.91 7.12 20.53 21.80 -3.40 21.68 -9.37 5.90 18.33
Sector Equity Healthcare - OE 2.67 -13.91 7.12 20.53 21.80 -3.40 21.68 -9.37 5.90 18.33
Sector Equity Healthcare - OE 2.67 -13.91 7.12 20.53 21.80 -3.40 21.68 -9.37 5.90 18.33
Sector Equity Healthcare - OE 2.67 -13.91 7.12 20.53 21.80 -3.40 21.68 -9.37 5.90 18.33
Sector Equity Healthcare - OE 2.67 -13.91 7.12 20.53 21.80 -3.40 21.68 -9.37 5.90 18.33

Portfolio

Documents

Related Insights

Our intellectual capital is readily available and central to our Knowledge Shared approach"
Related Insights
Biotech’s bear market – and early recovery – explained
2 Jul 2024
Timely & Topical

Biotech’s bear market – and early recovery – explained

Low valuations and accelerating innovation are helping biotech recover from one of its worst drawdowns on record.

6 min read

Hangover cure: Tapping into global growth with thematic equities
12 Jun 2024
Timely & Topical

Hangover cure: Tapping into global growth with thematic equities

Janus Henderson’s recent Global Investment Summit explored growth drivers in equities, noting record levels of innovation in healthcare and technology as well as developments in real estate and sustainability.

6 min read

Identifying AI opportunities in healthcare
22 May 2024
Timely & Topical

Identifying AI opportunities in healthcare

Artificial intelligence is only beginning to make inroads into the healthcare sector. Here’s how investors might benefit today.

5 min read